$9.50
-0.59-5.85%
At close: Sep 16, 5:00 PM EST
$9.50
N/A
After Hours: 4:00 PM EST
Atrium Therapeutics Inc
RNANASDAQ
Atrium Therapeutics Earnings & Forecasts
Atrium Therapeutics (RNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Atrium Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.77 | $-1.10 | $-1.09 | $-1.08 |
| Actual | $-1.18 | $-0.97 | $-1.59 | $-1.27 |
| Surprise | -53.3% | +11.8% | -45.9% | -17.6% |
| Revenue | ||||
| Estimate | $500000 | $2.0M | $2.0M | $2.1M |
| Actual | $3.0M | $19.6M | $860000 | $12.5M |
| Surprise | +500.8% | +881.8% | -57.0% | +498.4% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q1 '27E | Q2 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.83 | $-1.99 |
| Revenue | ||
| Consensus | — | — |
